Position in IBRX
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$191,750
New position
Shares Held
25,000
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Joel Isaacson & Co., LLC holds $3,643,523 across 6 Biotechnology names. IBRX ranks #4 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,067 | $2,369,686 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
10,247 | $662,263 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
506 | $225,949 | |
| 4 | IBRX |
ImmunityBio, Inc.
This page
|
25,000 | $191,750 | |
| 5 | EDIT |
Editas Medicine, Inc.
|
68,144 | $168,315 | |
| 6 | CGEN |
Compugen Ltd
|
12,000 | $25,560 |
All Filings in IBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $191,750 | 25,000 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||